Structure |
Chemical Name |
CAS |
MF |
 |
ethyl 6-bromo-2-(bromomethyl)-5-hydroxy-1-methyl-1H-indole-3-carboxylate |
149246-36-6 |
C13H13Br2NO3 |
 |
Dapoxetine impurity 50 |
|
|
 |
Doxofylline Impurity 18 |
|
|
 |
Dapoxetine impurity 63 |
|
|
 |
Dapoxetine impurity 57 |
|
|
 |
Bosutinib Impurity 2 (N-Desmethyl Bosutinib) |
380843-81-2 |
C25H27Cl2N5O3 |
 |
2-amino-1-(3,4-dihydroxyphenyl)ethan-1-one |
499-61-6 |
C8H9NO3 |
![Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester](/CAS/20210305/GIF/2267259-70-9.gif) |
Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester |
2267259-70-9 |
C17H17NO10S2 |
![7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-2-methyl-7-oxo-, (S)- (9CI)](/CAS/20210305/GIF/129798-65-8.gif) |
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-2-methyl-7-oxo-, (S)- (9CI) |
129798-65-8 |
C13H9F2NO4 |
 |
Sitagliptin EP Impurity 1 |
|
|
 |
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-, (αS,3aR,4R,6R,7aS)-, 2,2,2-trifluoroacetate (1:1) |
2363753-29-9 |
C17H29BF3NO4 |
 |
Beprostatin impurity 3 |
|
|
![endo-(±)-8-aza-8-isopropylbicyclo[3.2.1]oct-3-yl (hydroxymethyl)phenylacetate](/CAS/GIF/22235-81-0.gif) |
endo-(±)-8-aza-8-isopropylbicyclo[3.2.1]oct-3-yl (hydroxymethyl)phenylacetate |
22235-81-0 |
C19H27NO3 |
![8,11-Dioxa-3,5-diazadodecanoic acid, 12-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-10-(hydroxymethyl)-2,6-bis(1-methylethyl)-7-oxo-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, (2S,6S)-](/CAS/20210305/GIF/1654737-35-5.gif) |
8,11-Dioxa-3,5-diazadodecanoic acid, 12-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-10-(hydroxymethyl)-2,6-bis(1-methylethyl)-7-oxo-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, (2S,6S)- |
1654737-35-5 |
C29H44N12O10 |
![(1R,3r,5S,8R)-8-butyl-3-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-8-methyl-8-azabicyclo[3.2.1]octan-8-ium](/CAS/20211123/GIF/99571-66-1.gif) |
(1R,3r,5S,8R)-8-butyl-3-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-8-methyl-8-azabicyclo[3.2.1]octan-8-ium |
99571-66-1 |
C21H32NO3+ |
 |
1,3-dihydro-1-oxoisobenzofuran-5-carboxamide |
85118-25-8 |
C9H7NO3 |
 |
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one |
2446799-72-8 |
C25H28N8O2 |
 |
Troxipide Impurity 8 |
|
|
 |
Peramivir Impurity 12/11 |
|
|
 |
(1S,2R,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid |
|
|
 |
Ceftazidime Impurity IMPA |
|
|
 |
Pitavastatin Impurity 82 |
|
|
 |
Terbutaline EP Impurity B Complete Set |
|
|
 |
Peramivir Intermediate impurity 2 |
|
|
 |
Cetrorelix Impurity 8 (+L-Pro) |
|
|
 |
Peramivir Intermediate Impurity 44 |
|
|
 |
Peramivir Hydroxy Isomeric Impurity |
|
|
 |
Nintedanib impurity F drops |
|
|
 |
Favipiravir Impurities 1-19 |
|
|
 |
Ticagrelor Impurity 138X |
|
|
 |
Apremilast Impurity 999 |
|
|
 |
Pranoprofen Impurity C |
|
|
 |
Abiolone Impurity 24 |
|
|
 |
Deerasirox Impurity II |
|
|
 |
Brivaracetam Impurity 49 |
|
|
 |
Paroxetine EP Impurity J HCl |
|
|
 |
Brivaracetam Impurity 99 |
|
|
 |
Bendamustine Impurity 39 |
|
|
 |
AvatrombopagImpurity42 |
|
|
 |
(R)-4-(((R)-1-carboxy-2-((3-hydroxypropyl)thio)ethyl)amino)-3-hydroxy-4-oxobutanoic acid |
|
|
 |
Hydrazinecarboxamide, 2-(6-hydroxy-1-methyl-1H-indol-5-yl)- |
70063-07-9 |
C10H12N4O2 |
![1H-Pyrrole-3-carboxaldehyde, 1-[(5-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-](/CAS/20210305/GIF/2514742-82-4.gif) |
1H-Pyrrole-3-carboxaldehyde, 1-[(5-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)- |
2514742-82-4 |
C16H10ClFN2O3S |
 |
Crisaborole Impurity 20 |
|
|
 |
(Z)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide |
|
|
![(1S,3R,5S,6R)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate](/) |
(1S,3R,5S,6R)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
|
|
 |
Nicergoline EP Impurity IJ |
|
|
 |
Fulvestrant impurityABCDEFGHJKL |
|
|
![2-((6S,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate](/CAS/20210305/GIF/114696-04-7.gif) |
2-((6S,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate |
114696-04-7 |
C24H36O6 |
 |
Isavuconazole Impurity 49 |
|
|
 |
(R)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-methoxyethyl)-8-hydroxyquinolin-2(1H)-one |
|
|
 |
Avatrombopag Impurity 51 |
|
|
 |
Tafluprost Impurity 18 |
|
|
 |
Rosuvastatin Impurity 161 |
|
|
 |
Rosuvastatin Impurity 155 |
|
|
 |
Rosuvastatin Impurity 146 |
|
|
 |
Rosuvastatin Impurity 126 |
|
|
![(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen -2-yl)acetate](/CAS/20211123/GIF/29461-90-3.gif) |
(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen -2-yl)acetate |
29461-90-3 |
C18H21NO3S2 |
 |
Digoxin Impurity 2 |
|
|
 |
DUTP, 100MM SOLUTION |
94736-09-1 |
C9H16N2NaO14P3 |
 |
Oxacillin USP Impurity D |
|
|
 |
Oxacillin sodium EP impurity B |
|
|
 |
Doxylamine Impurity E |
|
|
 |
Phenoxymethylpenicillin Potassium EP Impurity F |
2714805-53-3 |
C15H20N2O4S |
 |
Methylprednisolone EP Impurity D1 |
|
|
 |
Nirmatrelvir Impurity 13 |
|
|
 |
2-Pyridinecarboxamide, 4-hydroxy-N-methyl- (9CI) |
611226-36-9 |
C7H8N2O2 |
 |
2-Pyridinemethanol, 4-hydroxy-3,5-dimethyl- (9CI) |
727375-13-5 |
C8H11NO2 |
 |
Bumetanide Impurity 22 |
|
|
 |
Rocuronium Bromide Impurity 32 、33 |
|
|
 |
Flucloxacillin Sodium Impurity X |
|
|
 |
Pitavastatin Impurity 98 |
|
|
 |
Perospirone Impurity 29 |
|
|
 |
Perospirone Impurity 24 |
|
|
 |
Perospirone Impurity 7 |
1002359-81-0 |
|
 |
2-methyl-4-(((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14- tetraen-1-yl)oxy)naphthalen-1-yl acetate |
|
|
 |
Paxlovid Impurity 17 |
|
|
 |
Related impurities of fluoxetine sodium 19 |
|
|
 |
Fondaparinux sodium impurity 16 |
|
|
 |
Fondaparinux Sodium Impurity 11 |
|
|
 |
Oxacillin Impurity E |
|
|
 |
AZOBENZENE-3-CARBOXYLICACID |
14474-22-7 |
C13H10N2O2 |
 |
Bosutinib Impurity 40 |
|
|
 |
Ticagrelor Impurity J&K |
|
|
 |
Olodaterol Impurity 24 |
|
|
 |
Miglitol Isomer ImpurityB |
|
|
![benzhydryl (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/) |
benzhydryl (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
 |
43,50-Dicarboxy-cyanoco balamin |
|
|
 |
(1R,4S) Sertraline Hydrochloride |
79896-32-5 |
C17H18Cl3N |
 |
4-Desmethoxy-4-chloro Omeprazole Sulfide |
220757-74-4 |
C16H16ClN3OS |
 |
N-Desmethyl Tamoxifen Hydrochloride |
15917-65-4 |
C25H27NO.ClH |
 |
(3S,5S)-Atorvastatin sodium salt |
501121-34-2 |
C33H35FN2O5 |
 |
2(1H)-Pyrazinone, 3-phenyl- |
2882-18-0 |
C10H8N2O |
![1H-Thieno[3,4-d]imidazole-4-valeric acid, hexahydro-2-oxo-, stereoisomer (8CI)](/CAS/20200515/GIF/21788-37-4.gif) |
1H-Thieno[3,4-d]imidazole-4-valeric acid, hexahydro-2-oxo-, stereoisomer (8CI) |
21788-37-4 |
C10H16N2O3S |
 |
pazufloxacin |
166665-94-7 |
C16H15FN2O4 |
 |
MK 485 |
28875-92-5 |
C10H14N2O4 |
 |
1,3-Dioxane-4-aceticacid,6-(cyanomethyl)-2,2-dimethyl-,(4R,6R)-(9CI) |
807312-27-2 |
C10H15NO4 |
 |
bromobenzarone |
94729-09-6 |
C17H13BrO3 |
 |
digoxigenin-bis(digitoxoside) |
5297-05-2 |
C35H54O11 |
 |
17 alpha-cyanomethyl-19-nortestosterone |
67473-36-3 |
C20H27NO2 |
 |
desmethylazelastine |
47491-38-3 |
C21H22ClN3O |